These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 35844369)

  • 21. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut Microbiota and Chronic Constipation: A Review and Update.
    Ohkusa T; Koido S; Nishikawa Y; Sato N
    Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microbiome and inflammatory bowel disease.
    Glassner KL; Abraham BP; Quigley EMM
    J Allergy Clin Immunol; 2020 Jan; 145(1):16-27. PubMed ID: 31910984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional protective mechanisms against gut inflammation.
    Viladomiu M; Hontecillas R; Yuan L; Lu P; Bassaganya-Riera J
    J Nutr Biochem; 2013 Jun; 24(6):929-39. PubMed ID: 23541470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet?
    Knox NC; Forbes JD; Van Domselaar G; Bernstein CN
    Curr Treat Options Gastroenterol; 2019 Mar; 17(1):115-126. PubMed ID: 30661163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gut microbiota and chronic inflammatory bowel disease].
    Konturek PC
    MMW Fortschr Med; 2022 Jul; 164(Suppl 7):12-15. PubMed ID: 35831743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the Gut Microbiome's Role in Inflammatory Bowel Disease: Insights and Interventions.
    Gyriki D; Nikolaidis C; Stavropoulou E; Bezirtzoglou I; Tsigalou C; Vradelis S; Bezirtzoglou E
    J Pers Med; 2024 May; 14(5):. PubMed ID: 38793089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics, prebiotics and amelioration of diseases.
    Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
    J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed.
    Larussa T; Abenavoli L; Fabiano G; Mancuso MA; Polimeni N; Dumitrascu DL; Luzza F
    Minerva Gastroenterol (Torino); 2021 Dec; 67(4):357-368. PubMed ID: 35040302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.
    Samanta S
    Anticancer Agents Med Chem; 2022; 22(4):605-628. PubMed ID: 33305713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease.
    Pavel FM; Vesa CM; Gheorghe G; Diaconu CC; Stoicescu M; Munteanu MA; Babes EE; Tit DM; Toma MM; Bungau S
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34203609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
    Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
    World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.